August 12, 2024 Press release - Regulatory Circio Holding ASA – NOK 1.5m requested from Atlas under NOK 10m rights issue commitment
July 26, 2024 Press release - Regulatory Circio Holding ASA – Information about the warrants issued in connection with the rights issue and new share capital registered
July 9, 2024 Press release - Regulatory Circio Holding ASA – Mandatory notification of trade by primary insiders and close associates related to the rights issue
July 8, 2024 Press release - Regulatory Circio Holding ASA – Last day of the subscription period in the rights issue
July 5, 2024 Press release - Regulatory Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders
July 3, 2024 Press release - Regulatory Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders
July 2, 2024 Press release - Regulatory Circio Holding ASA – Last day of trading in subscription rights in the rights issue
June 28, 2024 Press release - Regulatory Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders
June 26, 2024 Press release - Regulatory Circio invited to present circVec circular RNA technology at upcoming international RNA therapeutics conferences
June 24, 2024 Press release - Regulatory Circio Holding ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates
June 24, 2024 Press release - Regulatory Circio Holding ASA – Commencement for the subscription period for the rights issue
June 19, 2024 Press release - Regulatory Circio Holding ASA – Minutes from the annual general meeting 2024 and approval of Rights Issue
June 18, 2024 Press release - Regulatory Circio Holding ASA – Approval and publication of prospectus for the rights issue
June 18, 2024 Press release - Regulatory Circio Holding ASA – Updated key information relating to the rights issue
June 18, 2024 Press release - Regulatory Circio Holding ASA – Updated information to the notice of annual general meeting 2024
June 6, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversions of convertible bonds and change of the ratio of subscription rights in the Rights Issue
June 6, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
June 4, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
June 3, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
May 30, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
May 29, 2024 Press release - Regulatory Circio Holding ASA – Key information relating to the rights issue
May 29, 2024 Press release - Regulatory Circio announces financing that secures cash runway for twelve months
May 29, 2024 Press release - Regulatory Circio Holding ASA – Terms of the rights issue and related transactions
April 29, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
April 25, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
April 17, 2024 Press release - Regulatory Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus
April 17, 2024 Press release - Regulatory Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025
April 17, 2024 Press release - Regulatory Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment
March 27, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
March 21, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
March 19, 2024 Press release - Regulatory Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China
March 13, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
March 5, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
March 4, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
February 7, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
February 5, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
January 18, 2024 Press release - Regulatory Circio receives waiver of EUR 6.2 million in loans from Business Finland
January 12, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
January 10, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
January 4, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
